In this video interview, Ramita Tandon, chief biopharma officer at Walgreens, discusses the operational investments required ...

Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain’s $10 billion acquisition by private equity firm Sycamore. It is a rough era for national pharmacy chains like ...